{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiel26sg3nrrbhgjadnmqifgrqx5g6k4uznnh3juw2xav74nh37mke",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjfravaowvg2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih4qi6g5rthecxqcp4akjh3qdc2plegemi2orn7bq5uhei2asbchq"
    },
    "mimeType": "image/jpeg",
    "size": 150614
  },
  "path": "/2026/04/13/revolution-medicines-successful-treatment-pancreatic-cancer-daily-pill/?utm_campaign=rss",
  "publishedAt": "2026-04-13T12:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Cancer",
    "drug development",
    "STAT+"
  ],
  "textContent": "In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.",
  "title": "STAT+: Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill",
  "updatedAt": "2026-04-13T19:46:36.000Z"
}